|
|
Chronic Myelogenous Leukemia
|
|
Chronic Myelogenous Leukemia
Leukemia's pedaling foe Jan 22, 2006
...school together. In 1993, Jones was diagnosed with chronic myelogenous leukemia, a rare cancer of the bone marrow. Her situation ...
- Charlotte Observer,
A walk of love Jan 25, 2006
...agency, helped finance the development of a new drug called Gleevec which can normalize white blood cells in cancer patients with chronic myelogenous leukemia. ...
- Muscatine Journal,
HHMI: Howard Hughes Medical Institute: Studies Reveal How New Drug ... Jan 23, 2006
HHMI researchers have discovered how a new generation of drugs thwarts a deadly mutation that causes chronic myelogenous leukemia (CML). ...
- Webbolt Business News (subscription),
Bristol-Myers Squibb Company Reports Financial Results for the ... Jan 25, 2006
...of its New Drug Application (NDA) to the FDA for dasatinib, a SRC/ABL Kinase Inhibitor for the potential treatment of chronic myelogenous leukemia (CML). ...
- PR Newswire (press release),
Kosan Initiates Phase I Clinical Trial of Oral Hsp90 Inhibitor KOS ... Jan 25, 2006
Drug Administration and the European Medicines Agency for the treatment of multiple myeloma as well as another hematologic cancer, chronic myelogenous leukemia ...
- PR Newswire (press release),
ChemGenex Granted US Patent on Ceflatonin(R)'s Use for Treatment ... Jan 17, 2006
The patent is entitled "Treatment of chronic myelogenous leukemia, resistant or intolerant to ST1571, involving homoharringtonine alone or combined with other ...
- Yahoo! News (press release)
INNOVIVE Pharmaceuticals Licenses Potent Dual Bcr-Abl/Lyn Kinase ... Jan 5, 2006
INNOVIVE will develop NS-187 for the treatment of chronic myelogenous leukemia (CML) and anticipates commencing Phase I trials this year. ...
- Business Wire (press release),
Cancer patients find relief in specialized massage Jan 22, 2006
When she was pregnant with her second child, she was diagnosed with chronic myelogenous leukemia, a blood cancer, in February 2002. ...
- Anchorage Daily News,
Mom, Wife Loses Battle With Leukemia Jan 4, 2006
She was 27. She and her husband, Kenny, had been married only two months when she was diagnosed with chronic myelogenous leukemia in June 2004. ...
- Tampa Tribune,
(BW) Power3 Medical Products Updates IP Position Jan 18, 2006
...of Parkinson's Disease" and "Biomarkers for Diagnosis and Targeting of Resistance and Sensitivity to Imatinib Mesylate in Chronic Myelogenous Leukemia" will be ...
- Houston Chronicle,
Bristol-Myers Squibb Submits New Drug Application for Dasatinib Dec 28, 2005
...rolling submission of its New Drug Application (NDA) to the US Food and Drug Administration (FDA) for dasatinib to treat chronic myelogenous leukemia (CML) in ...
- Finanzen.net,
INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer ... Jan 9, 2006
...known as NS-187) is an orally bioavailable, rationally designed, dual Bcr-Abl and Lyn-kinase inhibitor for the treatment of chronic myelogenous leukemia (CML). ...
- Genetic Engineering News,
Breaking the cancer code Jan 1, 2006
...the cancer spread. Jay Weinstein found out he had chronic myelogenous leukemia in 1996, two weeks before his marriage. He was 36 ...
- DetNews.com,
Merck, Gilead in integrase-inhibitor race Jan 13, 2006
BMS' dasatinib expected to rival Gleevec (November 21, 2005) -- An analyst firm predicts Bristol Myers Squibb's chronic myelogenous leukemia drug dasatinib ...
- Science Daily (press release)
Nippon Shinyaku, INNOVIVE Pharmaceuticals Conclude Licensing ... Jan 6, 2006
NS-187, which is a molecular targeted agent in the preclinical stage, is intended for the treatment of chronic myelogenous leukemia (CML). ...
- Japan Corporate News (press release),
Allosteric inhibitors of Bcr-abl–dependent cell proliferation Jan 20, 2006
Chronic myelogenous leukemia (CML) is a myeloproliferative disorder characterized at the molecular level by the expression of Bcr-abl, a 210-kDa fusion protein ...
- Nature.com (subscription),
Pfizer, Perlegen Announce New Collaboration and Bristol-Myers ... Dec 29, 2005
The pharmaceutical and health-care products company said it completed the rolling submission for Dasatinib to treat chronic myelogenous leukemia in different ...
- Financial News USA (press release),
Paper in Cancer Research Further Validates Ambit Biosciences' ... Jan 16, 2006
The T315I mutation is the most common drug-resistant mutation in chronic myelogenous leukemia (CML) and confers resistance not only to Gleevec, but to all ...
- Business Wire (press release),
Drug maker to help woman Jan 6, 2006
...maker of Gleevec. The drug has been successful in controlling chronic myelogenous leukemia and a form of gastric cancer. Gregory, 69 ...
- Modesto Bee,
Helping Amy helps others who need cells Jan 12, 2006
An eighth-grader at Jefferson Middle School in Mt. Lebanon, Amy was diagnosed with chronic myelogenous leukemia in autumn 2003. ...
- Pittsburgh Post Gazette,
Bristol-Myers completes dasatinib FDA application Dec 28, 2005
Research)on Wednesday said it had completed an application to the US Food and Drug Administration for dasatinib as a treatment for chronic myelogenous leukemia ...
- Reuters
Protein Design Labs Becomes PDL BioPharma Jan 9, 2006
...infarction (AMI), and IV Busulfex(R) (busulfan), a pre-conditioning agent used in connection with bone marrow transplantation in chronic myelogenous leukemia. ...
- MSN Money
Slowly, Cancer Genes Tender Their Secrets Dec 28, 2005
By GINA KOLATA. Jay Weinstein found out that he had chronic myelogenous leukemia in 1996, two weeks before his marriage. He was a ...
- Spartanburg Herald Journal (subscription),
Randle's comeback tops list of Courier stories Jan 5, 2006
School on Feb. 21. The popular Ceres High senior was diagnosed with chronic myelogenous leukemia (CML) on Feb. 17. Randle's cancer ...
- Ceres Courier,
Discomfort no problem to save a life Jan 8, 2006
It was a perfect match, I'm told. And Friday, I met her -- a 12-year-old girl with chronic myelogenous leukemia who lives somewhere in Europe. ...
- NewsOK.com (subscription),
Slowly, Cancer Genes Tender Their Secrets Dec 28, 2005
Jay Weinstein found out that he had chronic myelogenous leukemia in 1996, two weeks before his marriage. A cervical carcinoma cell ...
- The Common Voice,
Carlos continues to give through bracelet sales Dec 28, 2005
Carlos would have been a junior at Salpointe Catholic High School. He was diagnosed with chronic myelogenous leukemia, a blood cancer, in November 2000. ...
- Tucson Citizen,
A Thanksgiving worth cheering for 23 Nov 2005
And that's saying something. Two years ago Dunlap was diagnosed with chronic myelogenous leukemia. She was 15 and a sophomore at the time. ...
- Columbia Falls Hungry Horse News,
Forskolin prohibits chronic myelogenous leukemia (CML) Nov 15, 2005
Scientists found that a plant extract called forskolin can inhibit growth of chronic myelogenous leukemia (CML) cells in cultures and mice by up to 90 percent ...
- Food Consumer,
Chronic myelogenous leukaemia, Forskolin may be effective in ... Nov 19, 2005
Researchers have identified a new pathway in the progression of chronic myelogenous leukemia ( CML ). They also discovered that ...
- Xagena.it,
The tumor suppressor protein phosphatase 2A offsets the BCR/ABL ... Nov 16, 2005
...of Cancer Cell, provides fresh insight into the molecular mechanisms that are involved in induction and progression of chronic myelogenous leukemia (CML), and ...
- Medical News Today (press release),
BMS' dasatinib expected to rival Gleevec Nov 21, 2005
21 (UPI) -- An analyst firm predicts Bristol Myers Squibb's chronic myelogenous leukemia drug dasatinib, which is currently in phase 2 trials, could be as ...
- Science Daily (press release)
Ayurvedic herb can halt leukemia spread Nov 15, 2005
An extract from the root of an ornamental plant found in India can suppress the progression of chronic myelogenous leukemia (CML), a new study by researchers ...
- Webindia123,
Koch Award Given To Pioneer Of Leukemia Research Oct 28, 2005
Brian J. Druker the2005 Robert Koch Prize for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type of ...
- All Headline News
MGI PHARMA and SuperGen Provide Regulatory Status Updates for ... Nov 15, 2005
...is currently being evaluated in a broad clinical development program in patients with MDS, acute myeloid leukemia (AML), chronic myelogenous leukemia, or CML ...
- PR Newswire (press release),
Phase II Study Suggests Gleevec® Is Safe and Effective for ... Oct 25, 2005
After Treatment With Imatinib-Mesylate in Patients With Failure After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia: Results of a ...
- Cancer Consultants (press release),
Leukemia Under the Microscope Nov 2, 2005
The main types of leukemia include acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia and chronic myelogenous leukemia. ...
- Daily Californian,
Conference examines role of chromosome changes in cancer Oct 28, 2005
Later that same year, she found that something similar happened in patients with chronic myelogenous leukemia; a crucial segment of chromosome 22 broke off and ...
- EurekAlert (press release),
Robert Koch Prize and Gold Medal Awarded Oct 28, 2005
He receives the prize for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type of blood cancer. ...
- PR Newswire (press release),
Health calendar Oct 31, 2005
The Leukemia and Lymphoma Society offers an education program 'Chronic Myelogenous Leukemia: Issues and Insights.' Dave and Buster's, 9333 Research Blvd. Free. ...
- Austin American-Statesman (subscription),
Plant Extract May Block Key Step in Blood Cancer Progression Nov 14, 2005
14 - Geneticists here have identified a key step in how chronic myelogenous leukemia (CML) transforms from the relatively indolent chronic phase to the blast ...
- MedPage Today,
Cell Genesys Reports Third Quarter 2005 Financial Results Nov 2, 2005
In addition, initial results from a Phase 2 trial of GVAX® vaccine for leukemia in patients with chronic myelogenous leukemia (CML) will be presented at the ...
- Yahoo! News (press release)
NCCN Releases Updated Treatment Guidelines for Non-Small Cell Lung ... Oct 27, 2005
Other recently updated NCCN guidelines include those for Acute Myeloid Leukemia (AML), Bone Cancer and Chronic Myelogenous Leukemia (CML). ...
- Business Wire (press release),
American Honored For Cancer Research Oct 28, 2005
J. Druker is awarded the 2005 Robert Koch Prize for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type ...
- All Headline News
Gleevec® Effective for Molecular and Cytogenetic Relapses ... Oct 26, 2005
...after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: Results of a ...
- Cancer Consultants (press release),
Connecticut girl waiting for marrow donor Nov 11, 2005
..."I can't ride anymore because I'm not supposed to be around animals while I have this disease." Hailey has chronic myelogenous leukemia. "It's overwhelming. ...
- WFSB,
OHSU professor receives major honor in Germany Oct 28, 2005
...in Berlin said Friday Druker earned the honor for for his pioneering discoveries concerning the development and therapy of chronic myelogenous leukemia, a type ...
- Portland Business Journal,
New prostate cancer clue Oct 28, 2005
The discovery that gene fusion is at the heart of chronic myelogenous leukemia, a disorder known as CML in which the body produces cancerous white blood cells ...
- Newsday,
Researchers Use New Method to Discover Gene Rearrangements That ... Oct 27, 2005
...the ABL gene. The resulting BCR-ABL fusion gene causes the development of chronic myelogenous leukemia. Epithelial tumors, such ...
- National Institutes of Health (press release)
Prostate cancer tied to genes Oct 28, 2005
If successful, it could be similar to Gleevec, which interferes with the workings of a fused gene that causes chronic myelogenous leukemia. ...
- Fort Lauderdale Sun Sentinel,
Cytokinetics, Incorporated Reports Third Quarter 2005 Financial ... Oct 26, 2005
...failed to respond to all standard therapies and the other clinical trial is enrolling patients with acute leukemia, chronic myelogenous leukemia or advanced ...
- Yahoo! News (press release)
SouthScape: A weekly roundup of things to do in South communities Oct 27, 2005
...of Mt. Lebanon, who has chronic myelogenous leukemia, will sponsor a blood and bone marrow drive, 9 am-3 pm Nov. 6, Mt. Lebanon ...
- Pittsburgh Post Gazette,
Marrow Recipient Meets Donor During Ceremony Celebrating 25,000 ... Nov 4, 2005
In 1986, Richard Tate, a 21-year Postal employee from Wilmington, DE, was diagnosed with chronic myelogenous leukemia, a slow-growing cancer of the white blood ...
- Yahoo! News (press release)
Marrow Recipient Meets Donor During Ceremony Celebrating 25,000 ... Nov 6, 2005
...the Registry to help save lives." In 1986, Richard Tate, a 21-year Postal employee from Wilmington, DE, was diagnosed with chronic myelogenous leukemia, a slow ...
- PR Newswire (press release),
Gene arrangements cause most cases of prostate cancer Oct 29, 2005
The resulting BCR-ABL fusion gene causes the development of chronic myelogenous leukemia, according to the National Cancer Institute. ...
- Food Consumer,
Fused genes may trigger prostate cancer Oct 28, 2005
...research led to the development of the leukemia pill, Gleevec®, a drug designed to target the BCR-ABL gene fusion that causes chronic myelogenous leukemia. ...
- Cancerfacts.com,
Fused genes trigger the development of prostate cancer Nov 1, 2005
...involved in prostate cancer, which would be analogous to Imatinib - a drug designed to target the BCR-ABL gene fusion that causes chronic myelogenous leukemia.
- Xagena.it,
Bristol-Myers Squibb Company Reports Financial Results for the ... Oct 28, 2005
Squibb plans to present Phase II data on dasatinib, a SRC/ABL Kinase Inhibitor being investigated for the treatment of chronic myelogenous leukemia (CML), at ...
- PR Newswire (press release),
CEPHEID LAUNCHES GENEXPERT IN MOLECULAR CLINICAL RESEARCH Oct 26, 2005
The BCR/ABL product is part of a broader program directed at investigating its potential use for monitoring patients with chronic myelogenous leukemia. ...
- Small Times
Cepheid Launches GeneXpert(R) System in the Molecular Clinical ... Oct 26, 2005
The BCR/ABL product is part of a broader program directed at investigating its potential use for monitoring patients with Chronic Myelogenous Leukemia (CML). ...
- Yahoo! News (press release)
Hemosol Announces Layoff of Employees Oct 28, 2005
...loss; Drug Delivery for the treatment of Hepatitis C and liver cancer; and Cell Therapeutics for the treatment of chronic myelogenous leukemia and chemotherapy ...
- PR Newswire (press release),
As RNAi Technology Progresses Companies Try to Increase Their ... Nov 3, 2005
...of RNAi are considered, in particular, the prospects of improving on existing treatment modalities for some cancers such as chronic myelogenous leukemia. ...
- Genetic Engineering News,
Antigenics Reports Third Quarter 2005 Financial Results and Recent ... Oct 27, 2005
...therapeutic cancer vaccine, in combination with Gleevec(R) (imatinib mesylate, Novartis), for the treatment of chronic myelogenous leukemia (CML) patients ...
- Business Wire (press release),
Blood tests can help determine cause of erectile dysfunction 02 Oct 2005
Question: In 1992, I was diagnosed as having CML (Chronic Myelogenous Leukemia). Later that year, I underwent a bone marrow transplant. ...
- Staunton News Leader
Chinese Leukemia Patients Join Clinical Drug Tests 02 Oct 2005
...to have shown great effects in stemming the growth of leukemia cells, especially among patients with progressive chronic myelogenous leukemia (CML), for which ...
- Korea Times
First Report Of Cancer Drug Gleevec As New Target Therapy For ... Sep 30, 2005
Leukemia (November 4, 2004) -- Ever since the approval of Gleevec in 2001, a cancer-cell-specific drug used to treat chronic myelogenous leukemia (CML), the ...
- Science Daily (press release)
'Light the Night' celebration in Reston to benefit cancer patients Sep 28, 2005
I was diagnosed with CML (chronic myelogenous leukemia) in March 2003, approximately six months after the death of my mother-in-law who, after battling colon ...
- TimesCommunity.com
Hopkins Geneticist Discovers Mutations In Cancer Cells That ... Sep 28, 2005
...have been implicated in several other cancers such as colorectal, breast and ovarian cancer, as well as chronic myelogenous leukemia, gastrointestinal stromal ...
- Science Daily (press release)
Cytokinetics and GlaxoSmithKline Amend Collaboration Agreement for ... Sep 27, 2005
...failed to respond to all standard therapies and the other clinical trial is enrolling patients with acute leukemia, chronic myelogenous leukemia or advanced ...
- PharmaLive.com (press release)
Army still on the march hoping to cure Amy Sep 22, 2005
Lebanon, was diagnosed with chronic myelogenous leukemia in autumn 2003, and since that time, she has been in and out of hospitals and must take daily ...
- Pittsburgh Post Gazette
Cancer Drug Might Fight Lethal Lung Hypertension Sep 28, 2005
Univerity Hospital Giessen. How did a drug best known for curing chronic myelogenous leukemia beat back hypertension? Unlike the ...
- Forbes
Medical notes Sep 28, 2005
For health professionals, ``CML Issues and Insights: A Nursing Education program on Chronic Myelogenous Leukemia.'' 330-836-1772. ...
- Akron Beacon Journal
New Lawsuits: Friday, Sept. 23 Sep 27, 2005
Steinberg claims he was exposed to and inhaled or otherwise absorbed large amounts of benzene which led to him developing chronic myelogenous leukemia on Sept. ...
- Madison County Record
Local Medical Team Develops Effective Leukemia Treatment Aug 30, 2005
...therapy by prescribing existing leukemia medicine, such as vincristine and daunorubicin, together with Glivec, a medicine for chronic myelogenous leukemia. ...
- Korea Times
Grant to fund leukemia study at Children's Sep 12, 2005
Center. The grant will allow the researchers to study the effects of the Rac GTPase protein in chronic myelogenous leukemia, or CML. ...
- Cincinnati Business Courier
Light The Night Walks Raise Funds For Blood Cancer Sep 15, 2005
...cholesterol. He did a series of blood work and I found out by happenstance I had chronic myelogenous leukemia," Schrader said. CML ...
- NBC 10.com
Highland Park Katrina efforts are unflagging Sep 22, 2005
It turned out that Registered Nurse Margaret Reina, who has survived chronic myelogenous leukemia for five years, was helping people who were evacuated to ...
- Pioneer Press Online
Hemosol Announces Proposed Private Placement Financing Sep 22, 2005
...loss; Drug Delivery for the treatment of Hepatitis C and liver cancer; and Cell Therapeutics for the treatment of chronic myelogenous leukemia and chemotherapy ...
- PR Newswire (press release)
Leukemia treatment raises survival rate Aug 30, 2005
...imatinib from 1995 to 2001. Imatinib is the standard treatment for chronic myelogenous leukemia. According to Professor Lee's journal ...
- Korea Herald (subscription)
Health calendar Sep 4, 2005
Twice a month. MOMS Resource Center, 1212 N. Broadway St., Suite 150, Santa Ana. (714) 972-2610. Chronic Myelogenous Leukemia. 6:30-8 pm second Monday. ...
- OCRegister (subscription)
Bristol-Myers Ties Revival Hopes to 3 New Drugs (Update3) Sep 9, 2005
...is seeking approval for dasatinib, which has yet to receive a brand name, for the treatment of a type of blood cancer called chronic myelogenous leukemia. ...
- Bloomberg
Bay Area Extra Sep 9, 2005
She is battling chronic myelogenous leukemia. Both women need marrow transplants, and the most likely match will be with a Latino donor. ...
- San Jose Mercury News
Golf tournament to benefit disease research Sep 9, 2005
The golf tournament raises funds for other myeloproliferative disorders, such as polycythemia vera, chronic myelogenous leukemia and myelofibrosis. ...
- Bethel Beacon
The human genome and cancer, workshop aims to build on agency ...30 Jul 2005
For example, GleevecTM is a molecularly targeted drug and has proven effective in the treatment of chronic myelogenous leukemia, gastrointestinal stromal tumor ...
- Mongabay.com
Cytokinetics, Incorporated Reports Second Quarter 2005 Financial ...Jul 27, 2005
...failed to respond to all standard therapies and the other clinical trial is enrolling patients with acute leukemia, chronic myelogenous leukemia or advanced ...
- Business Wire
Antigenics Reports Second Quarter 2005 Financial Results and ...Jul 28, 2005
...enrolling patients in an exploratory Phase 2 study of AG-858 in combination with Gleevec, for the treatment of chronic myelogenous leukemia (CML) patients ...
- Business Wire
Health calendarJul 27, 2005
Twice a month. MOMS Resource Center, 1212 N. Broadway St., Suite 150, Santa Ana. (714) 972-2610. Chronic Myelogenous Leukemia. 6:30-8 pm second Monday. ...
- OCRegister (subscription)
Bristol-Myers Squibb Announces Financial Results for the Second ...Jul 28, 2005
This internally-discovered compound, now known as dasatinib, is being investigated for the treatment of chronic myelogenous leukemia (CML). ...
- Yahoo News
A new kind of cancer fighterJul 23, 2005
...away. Tests revealed chronic myelogenous leukemia, or CML, a disease that causes bone marrow to produce too many white blood cells. ...
- OregonLive.com
Ambit Tags Drugs That Counter Gleevec ResistanceJul 27, 2005
For all the remarkable success of Gleevec, the Novartis drug that targets the BCR-ABL oncoprotein in chronic myelogenous leukemia, patients often develop ...
- Bio-IT World
McFadden buoyed by stem cell donationJul 23, 2005
...and more than 300 miles away in the Bronx, Adams went for a physical so he could play high school basketball and was diagnosed with chronic myelogenous leukemia ...
- Rochester Democrat and Chronicle
Patients turn to LR centerJul 24, 2005
...tackle. One kind of myeloproliferative disorder — chronic myelogenous leukemia — is readily treatable with drugs, Barlogie said. ...
- Arkansas Democrat-Gazette (subscription)
Rockefeller exits governor race, cites his healthJul 20, 2005
He said his own condition was not inherited. He said a cousin has chronic myelogenous leukemia, a condition similar to Rockefeller’s. ...
- Arkansas Democrat-Gazette (subscription)
National Cancer Institue Approves $10 Million Award For Oregon ...Jul 19, 2005
In developing the pill for chronic myelogenous leukemia, researchers used their knowledge of the molecular defect at the heart of the disease to develop the ...
- MedfordNews.com
Drive seeks help for 2 ill residentsJul 17, 2005
...member as a match. Dagata-Grist is a mother of two who was recently diagnosed with chronic myelogenous leukemia. Gary Ponico has ...
- Poughkeepsie Journal
$9 million grant to advance work on better way to diagnose ...Jul 5, 2005
...that function,� Dr. Chan said. Such a target has been identified for chronic myelogenous leukemia (CML). A drug then was developed ...
- Medical News Today
Very Much Alive, Thank YouJul 16, 2005
Gleevac, a drug that blocks the pathways that signal tumor cells to grow, has prolonged the lives of people with chronic myelogenous leukemia, another blood ...
- New York Times
BERGEN COUNTY BRIEFSJul 20, 2005
...who is battling cancer. Saladino, 39, is suffering from chronic myelogenous leukemia, a cancer of the bone marrow. A bone-marrow ...
- NorthJersey.com
Big boost: Small community helps out in a big wayJul 14, 2005
After learning one of her co-workers, Lynn Degata-Grist, had been stricken with chronic myelogenous leukemia, Karen Murphy asked Degata-Grist what she could do ...
- Harlem Valley Times
Health calendarJul 3, 2005
...(714) 633-6858. Chronic Myelogenous Leukemia. 6:30-8 pm second Monday. Hoag Memorial Hospital Presbyterian, One Hoag Drive, Cancer Center, Newport Beach. ...
- OCRegister (subscription)
Hemosol Selects IGIV as its First Therapeutic Protein Product for ...Jul 13, 2005
...loss; Drug Delivery for the treatment of Hepatitis C and liver cancer; and Cell Therapeutics for the treatment of chronic myelogenous leukemia and chemotherapy ...
- Yahoo News
Cancer drug slows poxvirus in miceJul 2, 2005
...are well known to cancer investigators because mutation of one family member, Abl, causes a rare form of cancer known as chronic myelogenous leukemia ( CML ). ...
- I-Newswire.com
Causes, incidence, and risk factors:Jul 5, 2005
The disease has similarities to polycythemia vera, chronic myelogenous leukemia, and myelofibrosis. Usually it affects people in middle age. ...
- rarediseases.about.com
This page is updated on a monthly basis if relevant articles are available. If you are looking for further information on
Chronic Myelogenous Leukemia
you may want to try searching the Internet using the Google search box below.
|
|
|
